Macrez P h, Paty J, Renou A M, Sabathie M
Ann Anesthesiol Fr. 1977;18(2):233-44.
Etomidate or R 26490 is a new hypnotic agent produced by JANSSEN and al. in 1971. The first human experimentation was performed in 1972. The authors used Etomidate for 300 anaesthetics given for neuroradiological investigations. Two protocols were used for study: 25 anaesthetics were given with Etomidate as sole anaesthetic to outline its specific properties; 275 angiographies were performed with a combination of Etomidate and fentanyl. In protocol no. 1, the mean consumption was for 1,85 mg/kg/h, in protocol no. 2, the mean consumption was of 0,9 mg/kg/h. Pharmacological study of this drug defines it as a short acting hypnotic agent of low toxicity. Clinical observation shows cardiovascular and respiratory stability. However, frequent myoclonias were noted, when Etomidate was given as a sole anaesthetic. EEG recording and evoked response encephalography helped to outline some effects of Etomidate on central nervous system.
依托咪酯或R 26490是扬森等人于1971年研制出的一种新型催眠药。1972年进行了首次人体试验。作者将依托咪酯用于300例神经放射学检查的麻醉。研究采用了两种方案:25例麻醉仅使用依托咪酯以概述其特殊性质;275例血管造影术采用依托咪酯与芬太尼联合使用。在方案1中,平均用量为1.85毫克/千克/小时,在方案2中,平均用量为0.9毫克/千克/小时。该药物的药理学研究将其定义为一种低毒性的短效催眠药。临床观察显示心血管和呼吸稳定。然而,当仅使用依托咪酯作为麻醉药时,会频繁出现肌阵挛。脑电图记录和诱发反应脑造影有助于概述依托咪酯对中枢神经系统的一些作用。